Sort
21,453 grants matching “tuberculosis”
Validation of urine/serum LAM in HIV/nonHIV TB suspects and POC Test Development
$558,656Delphi Chatterjee · Colorado State University · R01 · FY2021 · AI
BIOCHEMICAL BASIS OF DELAYED TYPE HYPERSENSITIVITY
$558,618Harvard University (Sch Of Public Hlth) · R01 · FY2000 · AI
Measure the metabolic and genetic factors that determine M. Tuberculosis
$558,427David Branch Moody · Brigham And Women'S Hospital · U19 · FY2019 · AI
Vanderbilt CTU SARS-CoV-2 Supplement
$558,406David W Haas · Vanderbilt University Medical Center · UM1 · FY2020 · AI
Infectious Disease/Basic Microbial Pathogenic Mechanisms
$558,388Daniel E Goldberg · Washington University · T32 · FY2017 · AI
Safe and Effective Vitamin D Supplementation in HIV
$558,288Virginia A. Stallings · Children'S Hosp Of Philadelphia · R01 · FY2010 · AT
Project 1: Listeria metabolites and innate immunity
$558,261Daniel A Portnoy · University Of California Berkeley · P01 · FY2022 · AI
Contribution of genetic variation to pharmacokinetic variability and toxicity in
$558,233Dissou Affolabi · Nat'L Hospital/Tuberculosis/Pul/Diseases · U01 · FY2016 · AI
Impact of a New Molecular TB Test on TB/HIV Outcomes among HIV-Infected Malawians
$558,148Richard E Chaisson · Johns Hopkins University · R01 · FY2014 · AI
A Novel Oral Combination Pediatric HIV and TB Vaccine
$557,895Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2009 · DE
Prevent TB: Application of choice architecture to implement TB preventive therapy in South Africa
$557,822Christopher J Hoffmann · Johns Hopkins University · R01 · FY2024 · AI
The necrosis-inducing toxin of Mycobacterium tuberculosis
$557,663Michael Niederweis · University Of Alabama At Birmingham · R01 · FY2016 · AI
Self-splicing Inteins: Function, Evolution, Application
$557,616Marlene Belfort · State University Of New York At Albany · R01 · FY2019 · GM
Self-splicing Inteins: Function, Evolution, Application
$557,616Marlene Belfort · State University Of New York At Albany · R01 · FY2018 · GM
Self-splicing Inteins: Function, Evolution, Application
$557,616Marlene Belfort · State University Of New York At Albany · R01 · FY2017 · GM
Chemical Mycobacteriology
$557,488Carolyn R Bertozzi · University Of California Berkeley · R01 · FY2011 · AI
Development Of A Vaccine For Leishmania Major Infection
$557,449Robert A Seder · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$557,449Robert A Seder · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Infectious Disease and Basic Microbiological Mechanisms
$557,149Marcia B Goldberg · Massachusetts General Hospital · T32 · FY2019 · AI
Antimicrobial Resistance in Bacteria
$556,890Stanley N Cohen · Stanford University · R01 · FY2011 · AI
Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis
$556,566Gillian L Beamer · Texas Biomedical Research Institute · R61 · FY2022 · AI
Metabolic biomarkers of TB disease, treatment response and infectiousness
$556,558Robin Wood · Brigham And Women'S Hospital · U19 · FY2021 · AI
Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis
$556,523Susan E Dorman · Medical University Of South Carolina · R01 · FY2020 · AI
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid
$556,460Thuy Le · Duke University · R01 · FY2025 · AI
RNA modification and antibiotic resistance
$556,322Graeme L Conn · Emory University · R01 · FY2020 · AI